Healthcare - Biotechnology - NASDAQ - US
$ 15.66
-5.49 %
$ 26 M
Market Cap
-2.33
P/E
INCOME STATEMENT
0
REVENUE
-7.63 M
OPERATING INCOME
-8.36 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Cadrenal Therapeutics, Inc. Common Stock
| Revenue | 0 |
| Cost Of Revenue | 1.98 K |
| Gross Profit | -1.98 K |
| Operating Expenses | 7.63 M |
| Operating Income | -7.63 M |
| Other Expenses | 724 K |
| Net Income | -8.36 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | |
|---|---|---|
| REVENUE | ||
| Revenue | 0 | 0 |
| GROSS PROFIT | ||
| Cost Of Revenue | 1.98 K | 1.27 K |
| Gross Profit | 1.98 K | 1.27 K |
| OPERATING INCOME | ||
| Operating Expenses | 7.6 | 2.7 |
| Selling, General and Administrative Expenses | 3.5 | 2.3 |
| Research and Development Expenses | 4.1 | 0.4 |
| Operating Income | (7.6) | (2.7) |
| PRE-TAX INCOME | ||
| Interest Income Expense | 17.1 K | 0.1 |
| Total Other Income | (0.7) | (4.0) |
| Pre-Tax Income | (8.4) | (6.7) |
| NET INCOME | ||
| Tax Provision | 0 | 4 |
| Net Income | (8.4) | (6.7) |
| EPS | 9.63 | 8.66 |